80 likes | 232 Views
Generic Industry’s Perspective on the New GMP Initiative. 2002 Generic Pharmaceutical Association Kenneth Lavin, M.Sc. Director, Regulatory Compliance TEVA Pharmaceuticals USA. Modernization and Consistent Enforcement of cGMPs is Needed:. Center and Field District to District.
E N D
Generic Industry’s Perspective on the New GMP Initiative 2002 Generic Pharmaceutical Association Kenneth Lavin, M.Sc. Director, Regulatory ComplianceTEVA Pharmaceuticals USA
Modernization and Consistent Enforcement of cGMPs is Needed: • Center and Field • District to District
Best Approach: Guidance Documents Needed • Examples: • Cleaning Validation • Process Validation • Training • Vendor Qualification
Cleaning Validation • Levels • Matrix Approach • Monitoring Program
Process Validation • Impact of Validation in Future Production • Lessen requirements for commercial production. • Unnecessary Testing.
Training • Level • Documentation / Tracking
Vendor Qualification • Repeat of testing • Reduced Testing • Documentation / Rational
Summary – Guidance • GPhA welcomes the opportunity to work with FDA, industry and academia on developing the science to create the procedure to allow for a new regulatory framework.